Company maintenance safety management template
Release time:
2020-08-14
Company's Maintenance Safety Management Template
News The maintenance safety control template compiled by the Security Management Office of the Group Company has been distributed to all units of the Company a few days ago and will be implemented from 2017 10# October .
The maintenance safety management template management method is based on the company's "Maintenance Safety Management System" and formats the contents of the maintenance safety management plan to form a unified template for the whole group. The template consists of three parts. The first part is a form. In the maintenance plan and organization stage, fill in the form for the implementation of relevant safety management matters, stipulate the prescribed procedures to be completed in the early stage such as safety coordination meeting, admission notification, inspection of maintenance safety tools, emergency material preparation, special operation classification, etc., and clarify and implement safety responsibilities through filling in the form. The second part is the safety management regulations during the maintenance stage, it stipulates the labor discipline at the maintenance site, matters needing attention in the use of various machines and tools, electricity regulations, prohibited items in special operations, protection and monitoring, etc., so as to strengthen the on-site safety management. The third part is the maintenance safety plan and supervision form. Through subdividing the maintenance items, the maintenance safety risk pre-analysis is carried out for each maintenance sub-item to determine the safety precautions to be taken, in addition, the security department has also designed a daily on-site inspection signature record column. The unified template of
stipulates that the safety control implementation plan shall be prepared before the planned maintenance, the maintenance safety management process shall be standardized, and the responsible persons at each stage shall be clearly defined. Each unit shall fill the actual contents of safety management into this template before carrying out maintenance, and hang the Safety Control Implementation Plan on the site after the maintenance starts, so as to facilitate the control of maintenance safety risks and facilitate the comparative inspection and supervision of safety control matters.
Once a safety accident occurs during equipment maintenance, it often causes serious harm and loss, so it has always been the focus of the company's safety management work. In the past, although each unit has formulated a maintenance safety system, the implementation is relatively arbitrary, there is a phenomenon that the system stays on paper and verbally, and the responsible person is often unclear when it comes to specific matters. In order to strengthen management, through the preparation of unified templates and kanban management, the safety management is integrated into the maintenance plan and specific maintenance tasks, which can make the maintenance safety management simple and controlled. The company hopes that all units will continue to innovate and supplement according to the actual situation in the process of template management, so as to make the maintenance safety template more perfect and effective. (Li Xiaoyin)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31